Publication | Open Access

Clinical assessment of five patients with BRWD3 mutation at Xq21.1 gives further evidence for mild to moderate intellectual disability and macrocephaly

Brwd3 MutationMendelian DisorderGenetic DisorderGeneticsFragile X SpectrumPathologyNeurologyDisease Gene IdentificationClinical AssessmentMedicineClinical GeneticsDevelopmental Delay